Background. Hematoporphyrin derivative (HpD, Hiporfin) is used for photodynamic therapy (PDT) of solid tumors but had never been evaluated for fluorescence guided resection (FGR) in glioma. We assessed Hiporfin fluorescence accuracy against histopathology in recurrent glioblastoma (rGBM) and the feasibility of adding cavity PDT to FGR.
Hiporfin (HpD) for fluorescence-guided resection of recurrent glioblastoma: diagnostic accuracy and feasibility of an integrated photodynamic strategy
calendar_today
October 9, 2026
person
He, Z., Zhang, G., Wang, C., Wu, L., Hu, W., Duan, H., Chen, Y., Lu, J., Yuan, Z., Zhang, X., Mou, Y.
domain
medrxiv